Don Sin (University of British Columbia, Vancouver, Canada; St Paul’s Hospital, Vancouver, Canada) speaks from the 2019 ATS conference in Dallas, TX, USA about the indicators that COPD is a disease of accelerated aging and the impacts of accelerated aging on patients. He also discusses the further work needs to be performed to understand COPD as a disease of accelerated aging and patient treatment responses.
Questions
1. How has our understanding of chronic obstructive pulmonary disease (COPD) changed over time? (0:04)
2. What indicators are there that COPD is a disease of accelerated aging and what are the impacts of accelerated aging on patients? (0:33)
3. Are there associations between indicators of aging and response to treatments such as azithromycin, and if so, what are the implications for patient management? (1:12)
4. What further work needs to be performed to understand COPD as a disease of accelerated aging and patient treatment responses? (1:52)
5. In a wider context, does the understanding of COPD as a disease of accelerated aging have implications for the unmet needs of patients with COPD? (2:24)
Speaker disclosure: Don Sin has nothing to disclose in relation to this video interview.
touchRESPIRATORY.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed at ATS 2019, Dallas, TX, USA, May 2019.
